Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Supha Pharmachem Ltd

Your Vote -

Buy

77.78%

Hold

11.11%

Sell

11.11%

77.78%

9 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Supha Pharmachem Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Supha Pharmachem - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    20 Jan 2026, 10:07AM Submission of Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31.12.2025
  • Remedium Lifecare has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025

    9 Jan 2026, 11:20AM As of December 2025, 1.13% is owned by Indian Promoters and 98.87% by Public. <p align=justify> Top Promoter holding highest number of shares of Remed
  • Remedium Lifecare - Announcement under Regulation 30 (LODR)-Change of Company Name

    15 Dec 2025, 11:34AM Company is pleased to informed that MCA has approved the change of name vide certificate of incorporation W.E.F. 15/12/2025 from REMEDIUM LIFECARE LTD
  • Remedium Lifecare - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    8 Dec 2025, 11:24AM Submission of postal ballot results and scrutinizer report
  • Remedium Lifecare - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    8 Dec 2025, 11:22AM Submission of outcome of postal ballot
  • Remedium Lifecare - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    17 Nov 2025, 8:57AM Remedium Lifecare Delivers Strong Q2 Results with Profit Nearly Doubling to Rs.862.34 Lakh
  • Remedium Lifecare Q2 net profit down 96.07% at Rs 0.07 cr

    14 Nov 2025, 7:25PM The company reported standalone net profit of Rs 0.07 crore for the quarter ended September 30, 2025 as compared to Rs 1.78 crore in the same period l
  • Remedium Lifecare - Results - Financial Results For Quarter And Half Year Ended September 30, 2025

    14 Nov 2025, 2:41PM Financial Results for Quarter and Half Year ended September 30, 2025
  • Remedium Lifecare - Board Meeting Outcome for Board Meeting Outcome For The Unaudited Financial Results (Standalone And Conso

    14 Nov 2025, 2:33PM Board Meeting Outcome for The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter and Half year Ended September 3
  • Remedium Lifecare - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    10 Nov 2025, 12:13PM Remedium Lifecare Strengthens Leadership for Next-Phase Growth
  • Remedium Lifecare - Board Meeting Intimation for To Consider And Approve Unaudited Standalone And Consolidated Results For Qu

    6 Nov 2025, 10:22AM Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider an
  • Remedium Lifecare - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    4 Nov 2025, 12:23PM Submission of postal ballot notice
  • Remedium Lifecare - Appointment Of Mr. Rambhajan Vishwakarma And Mr. Vignesh Laxman Gawde

    31 Oct 2025, 9:58PM Appointment
  • Remedium Lifecare - Board Meeting Outcome for Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements), Regulat

    31 Oct 2025, 9:56PM the Board in ite metting approved 1. Appointed Mr. Rambhajan Vishwakarma . 2. Appointed Mr. Vignesh Laxman Gawde . 3. Approved the Postal Ballot noti
  • Remedium Lifecare bags contract from UK-based Aster Biotech

    25 Jun 2024 , 12:23PM Remedium Lifecare bags multi-year supply contract worth Rs. 175 cr from UK-based Aster Biotech
  • Remedium Lifecare bags order in UAE

    28 Feb 2024 , 9:49AM Remedium Lifecare bags export order worth Rs. 169 cr from a pharma co in UAE

Key fundamentals

Evaluate the intrinsic value of Supha Pharmachem Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 1184.6883 100.6603 10.3643 4.9382 14.3591
Liabilities 1184.6883 100.6603 10.3643 4.9382 14.3591
Equity 40.32 10.08 3.6 3.6 3.6
Gross Profit -1.8107 33.3029 7.4713 1.7059 0.7109
Net Profit 1.532 32.7302 5.4261 1.0778 0.4805
Cash From Operating Activities 0 -74.1611 20.5 11.283 -10.2125
NPM(%) 0.68 0.8 1.06 0.21 0.53
Revenue 222.4976 4041.7067 509.8366 504.7919 90.0339
Expenses 224.3083 4008.4038 502.3653 503.086 89.323
ROE(%) 1.45 31.11 5.15 1.02 0.45

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Supha Pharmachem Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Neetu Yoshi Ltd 87.50 9.38 0.00 2.37 84.58 0.00
Resourceful Automobile Ltd 53.00 0.00 6.50 0.22 47.70 0.00
Kross Ltd 193.75 -1.05 25.12 5.35 148.90 0.00
Belrise Industries Ltd 171.10 6.41 33.37 54.03 79.89 0.00

Company Info

Remedium which engages in trading in API intermediates (KSMs & CRMs) and various other raw materials used in API trading. viz., Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Sulfoxonium Iodide(TMSI), has further strengthened its performance and presence in the pharma & healthcare domain. Remedium has made a paradigm shift by entering into the trading of intermediates and APIs and be reckoned as a leading contract trader and as a brand owner of advanced intermediates & APIs Remedium Lifecare Ltd. (formerly known as Roxy Exports Limited) is a BSE listed company. 2020 -Company name has changed to Remedium Lifecare Ltd. from Roxy Exports Ltd.. 2023 -Company has issued Bonus Shares in the Ratio of 9:5. -Company has splits its face value from Rs. 10/- to Rs. 5/-. 2020-Company name has changed to Remedium Lifecare Ltd. from Roxy Exports Ltd..2023-The Company has issued Bonus Shares in the Ratio of 9:5.2024-The Company has issued Bonus Shares in the Ratio of 3:1.2025-The company issued rights shares of Rs. 1 in the ratio of 61:50 at par.- Remlife Global Partners with JiyaYu to Replace Animal-Origin Inputs in APIs.

Remedium which engages in trading in API intermediates (KSMs & CRMs) and various other raw materials used in API trading. viz., Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Sulfoxonium Iodide(TMSI), has further strengthened its performance and presence in the pharma & healthcare domain. Remedium has made a paradigm shift by entering into the trading of intermediates and APIs and be reckoned as a leading contract trader and as a brand owner of advanced intermediates & APIs Remedium Lifecare Ltd. (formerly known as Roxy Exports Limited) is a BSE listed company. 2020 -Company name has changed to Remedium Lifecare Ltd. from Roxy Exports Ltd.. 2023 -Company has issued Bonus Shares in the Ratio of 9:5. -Company has splits its face value from Rs. 10/- to Rs. 5/-. 2020-Company name has changed to Remedium Lifecare Ltd. from Roxy Exports Ltd..2023-The Company has issued Bonus Shares in the Ratio of 9:5.2024-The Company has issued Bonus Shares in the Ratio of 3:1.2025-The company issued rights shares of Rs. 1 in the ratio of 61:50 at par.- Remlife Global Partners with JiyaYu to Replace Animal-Origin Inputs in APIs.

Read More

Parent Organisation

Supha Pharmachem Ltd.

Founded

19/02/1988

Managing Director

NSE Symbol

FAQ

The current price of Supha Pharmachem Ltd is

The 52-week high for Supha Pharmachem Ltd is

The market capitalization of Supha Pharmachem Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Supha Pharmachem Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Supha Pharmachem Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Supha Pharmachem Ltd shares.

The CEO of Supha Pharmachem Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT